GlassScriptPhysician profile
Ralph M Hadley
NPI 1295959211
$4,271.24
in general payments reported to CMS, 2019-2025
34 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $934 · 2022: $631 · 2023: $726 · 2024: $959 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,706.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $525.47 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $512.91 | 2021-2025 | |
| Novo Nordisk INC | $431.71 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $334.62 | 2021-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $326.89 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Axsome Therapeutics, INC. | $270.35 | 2024-2025 | Auvelity |
| Abbott Laboratories | $192.82 | 2022-2025 | Proclaim, Prodigy |
| Janssen Pharmaceuticals, INC | $175.58 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.43 | 2022-2025 | Jardiance |
| Mayne Pharma Commercial LLC | $134.35 | 2022 | |
| Exact Sciences Corporation | $125.29 | 2023-2025 | Cologuard Collection Kit |
| Galderma Laboratories, L.P. | $118.82 | 2021 | |
| Dexcom, INC. | $89.66 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $88.34 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $71.44 | 2021-2025 | Gardasil 9, Capvaxive, Lagevrio |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $62.49 | 2024-2025 | Otezla, Repatha, Repatha |
| Teva Pharmaceuticals USA, INC. | $61.26 | 2023-2024 | Austedo Xr |
| Ironshore Pharmaceuticals INC. | $54.94 | 2022-2023 | Jornay Pm |
| Tris Pharma INC | $53.53 | 2023-2024 | Dyanavel Xr |
| Genentech USA, INC. | $52.85 | 2021 | |
| Bausch Health US, LLC | $52.00 | 2022-2024 | Aplenzin |
| Biohaven Pharmaceutical Holding Company LTD. | $47.44 | 2022 | |
| Lundbeck LLC | $43.95 | 2022-2023 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.06 | 2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $36.72 | 2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $35.53 | 2024 | Rexulti |
| Stryker Corporation | $30.63 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $30.22 | 2021-2022 | |
| Corium, LLC | $25.38 | 2025 | Azstarys |
| Lupin INC. | $22.36 | 2021 | |
| Cranial Technologies, INC | $21.94 | 2021 | |
| Shield Therapeutics INC | $18.20 | 2025 | |
| Viiv Healthcare Company | $15.40 | 2025 | Apretude |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Hadley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.